This cost-effectiveness study developed an age- and sex-structured dynamic transmission model to simulate HPV infection and cervical cancer outcomes in Iran. It evaluated three vaccination strategies — vaccinating girls only, boys only, and both sexes — using incremental cost-effectiveness ratios (ICERs) measured in quality-adjusted life years (QALYs), benchmarked against GDP per capita thresholds.
Key findings:
The findings support girls-only HPV vaccination as a cost-effective strategy in Iran and highlight the importance of dynamic modeling for capturing long-term population-level benefits. Incorporating broader societal costs and additional HPV-related outcomes could further strengthen the economic case for vaccination.
How can the findings be used?
These findings can be used to inform national immunization policy in Iran by identifying HPV vaccination strategies that provide the greatest health gains for available resources.
Thumbnail image credit: Gavi
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.